Recurrent Vertigo after Intratympanic Gentamicin for Ménière’s Disease: Long-term Follow-up of Two Regimens

2013 ◽  
Vol 149 (2_suppl) ◽  
pp. P109-P109
Author(s):  
Augusto P. Casani ◽  
Niccolò Cerchiai ◽  
Iacopo Dallan ◽  
Elena Navari ◽  
Stefano S. Franceschini
2012 ◽  
Vol 127 (1) ◽  
pp. 20-24 ◽  
Author(s):  
J Wasson ◽  
N Upile ◽  
A Pfleiderer

AbstractObjective:To determine the long-term efficacy of a fixed-dose intratympanic gentamicin treatment regime in controlling unilateral Ménière's disease.Methods:Pfleiderer (1998) published two-year follow-up results for a series of 16 patients treated with a 4-day, 12-dose intratympanic gentamicin regime for unilateral Ménière's disease that was refractory to medical treatment. In 2010, a long-term telephone follow up (mean 17 years and 3 months) of this same cohort was conducted to determine long-term vertigo control. Of the 16 patients, 13 were eligible for the long-term follow up.Results:At 2 years' follow up, all 16 patients experienced substantial control of vertigo, with complete control achieved in 87 per cent of cases. At the long-term follow up, 9 of the 13 eligible patients were contactable, and all reported complete control of vertigo.Conclusion:Fixed-dose intratympanic gentamicin controlled symptomatic unilateral Ménière's disease in both the short and long term.


1996 ◽  
Vol 35 (3) ◽  
pp. 284
Author(s):  
Hirofumi Akagi ◽  
Koji Yuen ◽  
Kyoko Onoda ◽  
Teruhiro Ogawa ◽  
Kazunori Nishizaki ◽  
...  

1967 ◽  
Vol 85 (2) ◽  
pp. 156-170 ◽  
Author(s):  
A. Graybiel ◽  
H. F. Schuknecht ◽  
A. R. Fregly ◽  
E. F. Miller ◽  
M. E. McLeod

ORL ◽  
1991 ◽  
Vol 53 (3) ◽  
pp. 131-136 ◽  
Author(s):  
Tom Ohashi ◽  
Kentaro Ochi ◽  
Tomoyuki Okada ◽  
Isamu Takeyama

Sign in / Sign up

Export Citation Format

Share Document